Lina Hope
October 27, 2026
When the No Surprises Act (NSA) was signed into law at the tail end of 2020, it was hailed as a rare bipartisan triumph—a legislative shield designed to protect vulnerable patients from the financial trauma of "surprise billing." The core intent was simple: ensure that patients receiving emergency or specialty care at in-network facilities were not caught in the crossfire of billing disputes between insurers and out-of-network providers.
Nearly six years later, while the law has largely succeeded in shielding patients from egregious bills, the machinery behind the curtain is collapsing. What was envisioned as a streamlined, infrequent arbitration process has morphed into a chaotic, litigation-heavy quagmire that experts describe as "currently broken." With caseloads ballooning from a projected 22,000 per year to over 4 million in 2025 alone, the Independent Dispute Resolution (IDR) system is now the epicenter of a fierce, high-stakes battle between private equity-backed provider groups and powerful insurance conglomerates.
The Anatomy of a Legislative Failure
To understand why the system is failing, one must look at the intended mechanism. Under the NSA, when an insurer and an out-of-network provider cannot agree on a payment rate, they enter a "baseball-style" arbitration process. Each side submits an offer, and an arbitrator selects one. The process was designed to be anchored by the Qualifying Payment Amount (QPA), a metric intended to approximate the median rate for in-network care in a given geographic area.
"Congress came up with an IDR approach that, at the time, seemed like it would work well," explains Jack Hoadley, PhD, professor emeritus at the Center on Health Insurance Reforms at Georgetown University. "The expectation was that arbitration would be a modest backstop, used sparingly. The spirit of the law was compromise."
However, the "spirit of compromise" was quickly eroded by legal challenges and market incentives. When regulatory agencies initially suggested that the QPA should be the "default presumption" for arbitrators, the provider industry—fearing that insurers would use the QPA to suppress reimbursements—sued. Federal judges eventually struck down the QPA-as-default rule, ruling that arbitrators must weigh a broader array of factors. This opened the floodgates.
A Chronology of Systemic Decay
The degradation of the IDR process did not happen overnight. It was a gradual erosion driven by legal precedent and administrative overload.
- Late 2020: The No Surprises Act is signed into law, establishing the framework for the IDR process to handle out-of-network payment disputes.
- 2021-2022: Regulatory implementation begins. The government releases rules suggesting the QPA be the primary factor in arbitration. Provider groups file multiple lawsuits, arguing this unfairly favors insurers.
- 2023: Federal courts rule against the "QPA presumption," forcing the government to broaden the criteria for arbitrators.
- 2024: The volume of disputes begins to skyrocket. Private equity-backed physician groups, discovering that arbitrators favor their positions in roughly 85% of cases, adopt a "volume-first" strategy, flooding the system with claims.
- 2025: The system hits a breaking point. Annual disputes surpass 4 million, far exceeding the initial government projections of 22,000.
- October 2026: Legislative tensions reach a boiling point as new proposals emerge to either scrap the arbitration process entirely or impose severe penalties for non-payment of awards.
Supporting Data: Why the System is Overwhelmed
The statistical disparity between the initial projection and the current reality is staggering. Government analysts originally estimated that the IDR process would resolve approximately 22,000 disputes annually. The actual figure of 4 million disputes in 2025 represents an increase of nearly 18,000%.
Data from recent proceedings suggests that this is not merely a surge in legitimate disputes, but a systemic shift in tactical billing. Because arbitrators have favored providers in 85% of cases, the financial incentive for providers to enter arbitration is overwhelming. "That has created an incentive to ask for more and more money," Hoadley notes. "Even when plans offer more, they don’t seem to win any more often."
This has led to a secondary crisis: the refusal to pay. Josh Hill, JD, a partner at the law firm Pietragallo Gordon Alfano Bosick & Raspanti, highlights that insurers are increasingly ignoring arbitration awards. "The language of the statute is clear that these awards shall be paid within 30 days," Hill says. "It was an error on Congress’s part not to include a mechanism for what happens when they fail to pay. They can impose fines, but they can’t effectively enforce the payment of the award."
Official Responses and Political Friction
The legislative response has been polarized, reflecting the deep-seated animosity between providers and insurers.
The "Lower Premiums, Faster Payments Act"
Introduced on October 8, 2026, by Rep. Frank Pallone (D-N.J.), this bill proposes a radical surgery: eliminating the IDR process entirely and mandating the use of the QPA as the sole payment standard.
Proponents, including the consumer advocacy group Families USA, argue this is the only way to end the "industry abuse of arbitration." They contend that private equity firms are using the current system to extract inflated payouts, which ultimately drive up premiums for consumers. "This bill would take away the incentive for corporate middlemen to flood the system with disputes," the organization stated in a recent press release.
The Physician Response
Unsurprisingly, the medical community has reacted with fierce opposition. In a joint statement, the American Society of Anesthesiologists (ASA), the American College of Radiology (ACR), and the American College of Emergency Physicians (ACEP) slammed the proposal.
"Giving health insurance companies even greater control over physician payments is not the solution," said Patrick Giam, MD, president of the ASA. These groups argue that the problems in the IDR system stem from insurer practices and administrative failures, not from physician billing. They are urging Congress to reject the abolition of the IDR process and instead focus on "regulatory and court-directed reforms."
The Enforcement Approach
A competing legislative effort, championed by Rep. Greg Murphy, MD (R-N.C.), takes a more targeted approach. Rather than killing the IDR, his bill seeks to put teeth into enforcement by imposing heavy, mandatory penalties on insurers that fail to pay arbitration awards within the 30-day window.
Implications: A Looming Supreme Court Intervention?
The impasse is now moving from the halls of Congress into the federal court system. There is currently a split in how lower courts view the right of providers to sue for unpaid awards. While some courts have denied the right to sue, others have allowed it.
"If this continues, the Supreme Court could step in and say, ‘We need to figure this out,’" says Hill. A Supreme Court ruling could potentially force a definitive interpretation of the NSA’s enforcement mechanisms, but legal experts warn that a judicial fix is rarely as efficient as a legislative one.
As it stands, the No Surprises Act remains a cautionary tale of how even the best-intentioned policy can go awry when the underlying economic incentives are not fully stress-tested. For the American patient, the immediate threat of "surprise bills" has been mitigated, but the long-term stability of the health insurance market is now clouded by a mountain of unpaid claims and a legislative process that remains deadlocked.
For Hoadley, the conclusion is somber: "It probably does come down to Congress. They have to decide if they want to reinforce the QPA or find a new way to balance the scales. Right now, it’s not obvious what that answer is."
Nila Kartika Wati
Neng Nana
